Drug & Supplement Interactions

Docosahexaenoic Acid (DHA) + Rapacuronium

Brand name of Rapacuronium

  • Raplon

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated October 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line No Known Interaction

We found no known interaction between Docosahexaenoic Acid (DHA) and Rapacuronium in our sources.

This also applies to Raplon, a brand name of rapacuronium.

See the Full Interaction Report

Ask a Question About This Combination

Ask in your own words about taking Docosahexaenoic Acid (DHA) with Rapacuronium. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Docosahexaenoic Acid (DHA) and Rapacuronium Interaction Check

No Known Interaction Found

We did not find a documented interaction between Rapacuronium and Docosahexaenoic Acid (DHA) in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

How We Checked

Why No Interaction Is Listed for Rapacuronium

We sort drugs into categories, such as blood thinners or antibiotics, and many supplement interactions are recorded for a whole category rather than for one drug. So we checked every category Rapacuronium is in against every category Docosahexaenoic Acid (DHA) has a known interaction with.

1Category Rapacuronium Is In
  • Skeletal Muscle Relaxants No Docosahexaenoic Acid (DHA) Record
3Drug Categories Docosahexaenoic Acid (DHA) Interacts With

No overlap. Rapacuronium is in none of the 3 categories Docosahexaenoic Acid (DHA) interacts with, so no record links the two.

Still wondering about combining Docosahexaenoic Acid (DHA) and Rapacuronium? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Know someone taking this combination? Share
What to Watch For

What Docosahexaenoic Acid (DHA) Itself Has Been Linked To

  • This is not an interaction: nothing below involves Rapacuronium.
  • It is the side-effect record for Docosahexaenoic Acid (DHA) on its own, from the licensed Natural Medicines monograph.
  • If something new turns up after you add Docosahexaenoic Acid (DHA), this list is the first place to look.
  • 4 entries are worth acting on rather than waiting out, marked below.
  • An irregular heartbeat Worth Acting On Additional detail

    Orally, DHA might increase low-density lipoprotein (LDL) cholesterol levels. However, this appears to be primarily due to increases in the large buoyant type of LDL particles. The small, dense type of LDL particles are reduced.

    Prescription fish oil products in the U.S., which contain both DHA and eicosapentaenoic acid (EPA), must carry a warning regarding the risk for recurrent atrial fibrillation and flutter in adu…

    Source: , the clinical database we license.

    6 references cited
    1. 6143. Mori TA, Burke V, Puddey IB, et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 2000;71:1085-94. PubMed
    2. 48013. Nestel, P., Shige, H., Pomeroy, S., Cehun, M., Abbey, M., and Raederstorff, D. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am.J.Clin.Nutr. 2002;76(2):326-330. PubMed
    3. 48078. Engler, M. M., Engler, M. B., Malloy, M., Chiu, E., Besio, D., Paul, S., Stuehlinger, M., Morrow, J., Ridker, P., Rifai, N., and Mietus-Snyder, M. Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY
    4. 48083. Engler, M. M., Engler, M. B., Malloy, M. J., Paul, S. M., Kulkarni, K. R., and Mietus-Snyder, M. L. Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study). Am J Cardiol 4-1-2005;95(7):869-871. PubMed
    5. 48174. Kelley, D. S., Siegel, D., Vemuri, M., and Mackey, B. E. Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am J Clin Nutr 2007;86(2):324-333. PubMed
    6. 48338. Davidson MH, Maki KC, Kalkowski J, et al. Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled trial. J.Am.Coll.Nutr. 1997;16(3):236-243. PubMed
  • Wheezing Worth Acting On Additional detail

    Orally, worsened asthma symptoms were reported by one parent of one patient with asthma taking DHA 600 mg daily.

    Source: , the clinical database we license.

    1 reference cited
    1. 90699. Richardson AJ, Burton JR, Sewell RP, Spreckelsen TF, Montgomery P. Docosahexaenoic acid for reading, cognition and behavior in children aged 7-9 years: a randomized, controlled trial (the DOLAB Study). PLoS One. 2012;7(9):e43909. PubMed
  • Bleeding or bruising Worth Acting On Additional detail

    Orally, DHA might cause nose bleeds, but this is uncommon. Onset of severe nose bleeds has been reported in one clinical study in one child who took DHA 600 mg daily. Although most clinical research shows that DHA does not affect blood clotting when taken alone, there is some concern that taking high doses of oils providing DHA along with eicosapentaenoic acid (EPA) might decrease blood coagulation and increase the r…

    Source: , the clinical database we license.

    6 references cited
    1. 98542. Montgomery P, Spreckelsen TF, Burton A, Burton JR, Richardson AJ. Docosahexaenoic acid for reading, working memory and behavior in UK children aged 7-9: A randomized controlled trial for replication (the DOLAB II study). PLoS One. 2018;13(2):e0192909. PubMed
    2. 11112. Leng GC, Smith FB, Fowkes FG, et al. Relationship between plasma essential fatty acids and smoking, serum lipids, blood pressure and haemostatic and rheological factors. Prostaglandins Leukot Essent Fatty Acids 1994;51:101-8. PubMed
    3. 11113. Nelson GJ, Schmidt PS, Bartolini GL, et al. The effect of dietary docosahexaenoic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 1997;32:1129-36. PubMed
    4. 48020. Woodman, R. J., Mori, T. A., Burke, V., Puddey, I. B., Barden, A., Watts, G. F., and Beilin, L. J. Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients PubMed
    5. 1313. FDA. Center for Food Safety and Applied Nutrition. Letter regarding dietary supplement health claim for omega-3 fatty acids and coronary heart disease. Available at: http://www.fda.gov/ohrms/dockets/dockets/95s0316/95s-0316-Rpt0272-38-Appendix-D-Reference
    6. 95739. FDA announces qualified health claims for omega-3 fatty acids. Available at: https://www.fda.gov/Food/LabelingNutrition/ucm072756.htm. Accessed April 15 2019.
  • A higher chance of infection Worth Acting On Additional detail

    Orally, DHA may cause gastrointestinal upset, fishy aftertaste, belching, flatulence, heartburn, loose stools, anorexia, and dry mouth. There is also some evidence that increased serum levels of DHA might be associated with an increased risk for atrophic gastritis associated with Helicobacter pylori infection, but further research is needed to clarify this finding.

    For fish oils containing EPA and DHA, side effects c…

    Source: , the clinical database we license.

    6 references cited
    1. 10869. Marangell LB, Martinez JM, Zboyan HA, et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 2003;160:996-8.. PubMed
    2. 11333. Wheaton DH, Hoffman DR, Locke KG, et al. Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa. Arch Ophthalmol 2003;121:1269-78. PubMed
    3. 48217. Mischoulon D, Best-Popescu C, Laposata M, et al. A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. Eur Neuropsychopharmacol. 2008;18(9):639-645. PubMed
    4. 109218. Garmendia ML, Casanello P, Flores M, Kusanovic JP, Uauy R. The effects of a combined intervention (docosahexaenoic acid supplementation and home-based dietary counseling) on metabolic control in obese and overweight pregnant women: the MIGHT study. Am J O PubMed
    5. 8709. Ito Y, Suzuki K, Imai H, et al. Effects of polyunsaturated fatty acids on atrophic gastritis in a Japanese population. Cancer Lett 2001;163:171-8. PubMed
    6. 1009. Grimsgaard S, Bonaa KH, Hansen JB, Nordoy A. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr 1997;66:649-59.

    Orally, DHA may cause watery eyes but results are inconsistent. In one clinical study, five of 167 infants fed formula containing 0.32% or 0.64% DHA experienced watery eyes. However, none of the infants fed formula containing 0.96% DHA experienced watery eyes. In one clinical study, one patient taking DHA 400 mg daily experienced an ear infection. It is unclear if this event was related to DHA supplementation.

    Source: , the clinical database we license.

    1 reference cited
    1. 90670. Birch EE, Carlson SE, Hoffman DR, et al. The DIAMOND (DHA Intake And Measurement Of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexa
  • Heartburn / Dry mouth Additional detail

    Recorded for Docosahexaenoic Acid (DHA) in the same Natural Medicines adverse-effect record shown under A higher chance of infection above.

  • Acne / Hair loss Additional detail

    Orally, DHA has been associated with one report of rash and one report of warmth on hands in one clinical study. In another clinical study, two patients taking DHA 400 mg daily reported acne. In another clinical study, one parent of a pediatric patient treated with DHA 600 mg daily reported increased hair loss beginning 6 weeks after completion of supplementation.

    Source: , the clinical database we license.

    3 references cited
    1. 48217. Mischoulon D, Best-Popescu C, Laposata M, et al. A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. Eur Neuropsychopharmacol. 2008;18(9):639-645. PubMed
    2. 11333. Wheaton DH, Hoffman DR, Locke KG, et al. Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa. Arch Ophthalmol 2003;121:1269-78. PubMed
    3. 90699. Richardson AJ, Burton JR, Sewell RP, Spreckelsen TF, Montgomery P. Docosahexaenoic acid for reading, cognition and behavior in children aged 7-9 years: a randomized, controlled trial (the DOLAB Study). PLoS One. 2012;7(9):e43909. PubMed
  • Bloating or gas Additional detail

    Recorded for Docosahexaenoic Acid (DHA) in the same Natural Medicines adverse-effect record shown under Bleeding or bruising above.

  • Anxiety or restlessness Additional detail

    Orally, DHA may cause dizziness, headache, insomnia, fatigue, and anxiety. In one clinical study, one parent of a pediatric patient treated with DHA 600 mg daily reported increased disruptive behavior in the child.

    Source: , the clinical database we license.

    4 references cited
    1. 10869. Marangell LB, Martinez JM, Zboyan HA, et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 2003;160:996-8.. PubMed
    2. 11333. Wheaton DH, Hoffman DR, Locke KG, et al. Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa. Arch Ophthalmol 2003;121:1269-78. PubMed
    3. 48217. Mischoulon D, Best-Popescu C, Laposata M, et al. A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. Eur Neuropsychopharmacol. 2008;18(9):639-645. PubMed
    4. 90699. Richardson AJ, Burton JR, Sewell RP, Spreckelsen TF, Montgomery P. Docosahexaenoic acid for reading, cognition and behavior in children aged 7-9 years: a randomized, controlled trial (the DOLAB Study). PLoS One. 2012;7(9):e43909. PubMed

Showing the 10 most notable of 19 recorded effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

Everything above comes from the Natural Medicines adverse-effect record for Docosahexaenoic Acid (DHA) — expand a row for the licensed statement it rests on. We haven’t matched Rapacuronium to its FDA label in our system yet, so we can’t compare its own side-effect list here — the leaflet that comes with your prescription is the authoritative list for Rapacuronium.

If You Decide to Take Both
  • Add one new thing at a time, and note the date you started it.
  • A start date turns “I’ve been feeling off” into something a pharmacist can work with.
  • Do not stop a prescribed medicine on your own.
  • Check with your pharmacist or doctor before changing any medicine or supplement, especially if you take several or have an ongoing health condition.

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Docosahexaenoic Acid (DHA) Does Interact With Other Medications

Docosahexaenoic Acid (DHA) has 375 moderate known drug interactions in our database — Rapacuronium isn’t one of them. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Docosahexaenoic Acid (DHA)

Covers the 2,830 medications we’ve checked against Docosahexaenoic Acid (DHA). Pick one to open its full report.

Alternatives for the Same Use

Other Supplements Studied for Hyperlipidemia, and How They Mix With Rapacuronium

Choosing a supplement while you take Rapacuronium? Here are other options studied for hyperlipidemia, and whether each has a documented interaction with Rapacuronium.

1 of them has a documented interaction with Rapacuronium: Magnesium (moderate).

40 other supplements have at least some evidence of a benefit for hyperlipidemia; the 8 below come first. Docosahexaenoic Acid (DHA) itself is graded for it.

  • Magnesium Graded Moderate
  • Barley Graded No Known Interaction
  • Beta-glucans Graded No Known Interaction
  • Blond Psyllium Graded No Known Interaction
  • Oats Graded No Known Interaction
  • Plant Sterols Graded No Known Interaction
  • Alpha-lipoic Acid Graded No Known Interaction
  • Artichoke Graded No Known Interaction

The grades come from the Natural Medicines database and describe the research so far, not a recommendation, and none of these supplements replaces a prescribed medicine.

Everything Else You Take

See Every Supplement That Interacts With Rapacuronium

Take other supplements too? 3 supplements have a documented interaction with Rapacuronium, each explained on its page.

By severity: 1 major and 2 moderate.

The Most Serious There Right Now:

Open the Rapacuronium interaction pageEvery supplement checked against Rapacuronium, ranked by severity
Supplement

About Docosahexaenoic Acid (DHA)

Docosahexaenoic Acid (DHA)

DHA is an omega-3 fatty acid found in fatty fish and algae that is a building block for the brain, nervous system, and eyes. It is widely used and generally well tolerated, with the strongest support for fetal/infant development and lowering triglycerides; evidence for many other uses is mixed. Talk with your pharmacist or doctor before starting, especially if you are pregnant, have a bleeding risk, or take blood thinners.

Full Docosahexaenoic Acid (DHA) guide: uses, dosage, safety and every interaction

On Its Own

Docosahexaenoic Acid (DHA) Safety

Safety at a Glance

How Docosahexaenoic Acid (DHA) Is Rated

  • Docosahexaenoic Ac... Overall

    Generally safe

    DHA is generally well tolerated at typical supplement doses for most adults.

  • Pregnancy

    Likely Safe

    When used orally and appropriately. An intake of DHA 650 mg daily from food and/or supplements during pregnancy seems to be required to prevent a reduction in DHA status before delivery.

    Read the full pregnancy detail ↓
  • Breastfeeding

    Likely Safe

    When used orally and appropriately. An intake of DHA 650 mg daily from food and/or supplements during pregnancy seems to be required to prevent a reduction in DHA status before delivery.

    Read the full breastfeeding detail ↓

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center), with the full detail in the next card.

Special Populations

Docosahexaenoic Acid (DHA) in Pregnancy & Breastfeeding

Pregnancy And Lactation Likely Safe

When used orally and appropriately. An intake of DHA 650 mg daily from food and/or supplements during pregnancy seems to be required to prevent a reduction in DHA status before delivery. DHA is commonly used during pregnancy and lactation and is a component of some prenatal supplements. DHA is a normal component of breast milk, with higher levels in breast milk following term vs. preterm pregnancies. When taken as a prenatal supplement, DHA increases DHA levels in breast milk. Doses of DHA ranging from 300-800 mg daily beginning as early as the first trimester of pregnancy have been used safely in clinical research. When taken during lactation, DHA increases DHA levels in breast milk. When initiated within 72 hours of delivery of a very preterm infant, taking DHA 1.2 grams daily increases DHA levels in breast milk within 14 days. One study found that DHA supplementation during lactation increased the risk of bronchopulmonary dysplasia in breast-feeding infants born less than 29 weeks gestational age; however, it is unclear if this was due to DHA or various confounding factors. The tolerable upper intake level of DHA during pregnancy or lactation has not been established; most experts recommend DHA 200-300 mg daily. While it is typically advised that this need is met by consuming 8-12 ounces of seafood weekly during pregnancy and 4-8 ounces weekly during lactation, those with nutrient deficiency or those following a vegan diet may meet this need with supplementation.

DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.© 2026 Therapeutic Research Center

More to Explore

More Pairs and Interactions to Check

Keep Checking

Other Drugs & Docosahexaenoic Acid (DHA)

Browse every other medication we’ve checked against Docosahexaenoic Acid (DHA) — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
375Moderate
0Minor
2,454No known interaction
Moderate

Moderate: 375 interactions

Showing 60 of 375 moderate interactions — see all 375 on the Docosahexaenoic Acid (DHA) page.

No Interaction 2,454 drugs checked — show the list
How Much People Look This Up

Where Docosahexaenoic Acid (DHA) and Rapacuronium Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Docosahexaenoic Acid (DHA)
Top half

#439 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Rapacuronium
Top half

#1,235 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Docosahexaenoic Acid (DHA) and Rapacuronium Together: Common Questions

Can you take Docosahexaenoic Acid (DHA) with Rapacuronium?
We do not list a known interaction between Docosahexaenoic Acid (DHA) and Rapacuronium. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Can you take Docosahexaenoic Acid (DHA) with Raplon?
Raplon is a brand name of rapacuronium, so the answer is the same as for rapacuronium. We do not list a known interaction between Docosahexaenoic Acid (DHA) and Rapacuronium. Everything on this page applies to Raplon too.
How was the Docosahexaenoic Acid (DHA) and Rapacuronium combination checked?
Interactions in our licensed database are recorded against drug classes. Rapacuronium is filed under 1 classification, and Docosahexaenoic Acid (DHA) has documented interactions with 3 drug classes — none of Rapacuronium's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Do other supplements studied for hyperlipidemia interact with Rapacuronium?
1 of the 40 other supplements the Natural Medicines database grades as having some evidence of a benefit for hyperlipidemia has a documented interaction with Rapacuronium: Magnesium (moderate). A grade is the research so far, not a recommendation, and no known interaction is not proof of safety; ask your pharmacist before adding one.
Does Docosahexaenoic Acid (DHA) interact with any other medications?
Yes. Docosahexaenoic Acid (DHA) has 375 documented drug interactions in our database — Rapacuronium is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Rapacuronium interact with any supplements?
Yes. Rapacuronium has documented interactions with 3 supplements in our database — Docosahexaenoic Acid (DHA) is not one of them. The Rapacuronium interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Evidence & Sources

References Cited on This Page

The 20 references the cards above cite, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

Show the 20 references
  1. 1009. Grimsgaard S, Bonaa KH, Hansen JB, Nordoy A. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr 1997;66:649-59.
  2. 1313. FDA. Center for Food Safety and Applied Nutrition. Letter regarding dietary supplement health claim for omega-3 fatty acids and coronary heart disease. Available at: http://www.fda.gov/ohrms/dockets/dockets/95s0316/95s-0316-Rpt0272-38-Appendix-D-Reference
  3. 6143. Mori TA, Burke V, Puddey IB, et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 2000;71:1085-94. PubMed
  4. 8709. Ito Y, Suzuki K, Imai H, et al. Effects of polyunsaturated fatty acids on atrophic gastritis in a Japanese population. Cancer Lett 2001;163:171-8. PubMed
  5. 10869. Marangell LB, Martinez JM, Zboyan HA, et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 2003;160:996-8.. PubMed
  6. 11112. Leng GC, Smith FB, Fowkes FG, et al. Relationship between plasma essential fatty acids and smoking, serum lipids, blood pressure and haemostatic and rheological factors. Prostaglandins Leukot Essent Fatty Acids 1994;51:101-8. PubMed
  7. 11113. Nelson GJ, Schmidt PS, Bartolini GL, et al. The effect of dietary docosahexaenoic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 1997;32:1129-36. PubMed
  8. 11333. Wheaton DH, Hoffman DR, Locke KG, et al. Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa. Arch Ophthalmol 2003;121:1269-78. PubMed
  9. 48013. Nestel, P., Shige, H., Pomeroy, S., Cehun, M., Abbey, M., and Raederstorff, D. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am.J.Clin.Nutr. 2002;76(2):326-330. PubMed
  10. 48020. Woodman, R. J., Mori, T. A., Burke, V., Puddey, I. B., Barden, A., Watts, G. F., and Beilin, L. J. Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients PubMed
  11. 48078. Engler, M. M., Engler, M. B., Malloy, M., Chiu, E., Besio, D., Paul, S., Stuehlinger, M., Morrow, J., Ridker, P., Rifai, N., and Mietus-Snyder, M. Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY
  12. 48083. Engler, M. M., Engler, M. B., Malloy, M. J., Paul, S. M., Kulkarni, K. R., and Mietus-Snyder, M. L. Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study). Am J Cardiol 4-1-2005;95(7):869-871. PubMed
  13. 48174. Kelley, D. S., Siegel, D., Vemuri, M., and Mackey, B. E. Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am J Clin Nutr 2007;86(2):324-333. PubMed
  14. 48217. Mischoulon D, Best-Popescu C, Laposata M, et al. A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. Eur Neuropsychopharmacol. 2008;18(9):639-645. PubMed
  15. 48338. Davidson MH, Maki KC, Kalkowski J, et al. Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled trial. J.Am.Coll.Nutr. 1997;16(3):236-243. PubMed
  16. 90670. Birch EE, Carlson SE, Hoffman DR, et al. The DIAMOND (DHA Intake And Measurement Of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexa
  17. 90699. Richardson AJ, Burton JR, Sewell RP, Spreckelsen TF, Montgomery P. Docosahexaenoic acid for reading, cognition and behavior in children aged 7-9 years: a randomized, controlled trial (the DOLAB Study). PLoS One. 2012;7(9):e43909. PubMed
  18. 95739. FDA announces qualified health claims for omega-3 fatty acids. Available at: https://www.fda.gov/Food/LabelingNutrition/ucm072756.htm. Accessed April 15 2019.
  19. 98542. Montgomery P, Spreckelsen TF, Burton A, Burton JR, Richardson AJ. Docosahexaenoic acid for reading, working memory and behavior in UK children aged 7-9: A randomized controlled trial for replication (the DOLAB II study). PLoS One. 2018;13(2):e0192909. PubMed
  20. 109218. Garmendia ML, Casanello P, Flores M, Kusanovic JP, Uauy R. The effects of a combined intervention (docosahexaenoic acid supplementation and home-based dietary counseling) on metabolic control in obese and overweight pregnant women: the MIGHT study. Am J O PubMed

All 58 references behind our Docosahexaenoic Acid (DHA) records are listed in the Docosahexaenoic Acid (DHA) guide.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is reviewed by the HelloPharmacist Editorial Team. See our data sources and editorial standards.

Where Does Our Data Come From?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 105,612 references behind our interaction content, 67,053 of them resolved to verified PubMed/DOI sources. See the references behind this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified November 22, 2026. The Docosahexaenoic Acid (DHA) and Rapacuronium records this page draws on were last updated October 13, 2026.
Data structure & sourcing designed and verified by .
Rating Key

What Our Interaction Ratings Mean

No interaction is on record for this pair. The other supplements and medicines on this page carry a severity rating: how serious an interaction between them is.

See what each severity means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Still Have a Question About Docosahexaenoic Acid (DHA) and Rapacuronium?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.